143 related articles for article (PubMed ID: 7710352)
1. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.
Kintner RL; Allan RW; Brandt CR
Arch Virol; 1995; 140(2):231-44. PubMed ID: 7710352
[TBL] [Abstract][Full Text] [Related]
2. Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant.
Brandt CR; Kolb AW; Shah DD; Pumfery AM; Kintner RL; Jaehnig E; Van Gompel JJ
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2657-68. PubMed ID: 12766070
[TBL] [Abstract][Full Text] [Related]
3. Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.
Mott KR; Wechsler SL; Ghiasi H
Mol Vis; 2010 Oct; 16():2153-62. PubMed ID: 21139679
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase and susceptibility to interferon are not involved in the increased virulence of recombinant viruses isolated following mixed ocular infection with HSV strains OD4 and CJ394.
Pumfery AM; Brandt CR
Ophthalmic Res; 1996; 28(2):125-9. PubMed ID: 8792363
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the Herpes simplex 1 internal repeat sequences affects pathogenicity in the mouse.
Jenkins FJ; Donoghue AM; Martin JR
Front Biosci; 1996 Oct; 1():a59-68. PubMed ID: 9159195
[TBL] [Abstract][Full Text] [Related]
6. Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.
Kato A; Ando T; Oda S; Watanabe M; Koyanagi N; Arii J; Kawaguchi Y
J Virol; 2016 Jun; 90(12):5622-5635. PubMed ID: 27030266
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2002 Sep; 76(18):9069-78. PubMed ID: 12186890
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine 116 of the herpes simplex virus type 1 IEalpha22 protein is an ocular virulence determinant and potential phosphorylation site.
Brandt CR; Kolb AW
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4601-7. PubMed ID: 14578374
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.
Kolb AW; Lee K; Larsen I; Craven M; Brandt CR
PLoS Pathog; 2016 Mar; 12(3):e1005499. PubMed ID: 26962864
[TBL] [Abstract][Full Text] [Related]
10. Functional hierarchy of herpes simplex virus type-1 membrane proteins in corneal infection and virus transmission to ganglionic neurons.
Kim IJ; Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Dec; 39(12):1169-77. PubMed ID: 24749493
[TBL] [Abstract][Full Text] [Related]
11. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
[TBL] [Abstract][Full Text] [Related]
12. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants.
Smith TJ; Morrison LA; Leib DA
J Virol; 2002 Mar; 76(5):2054-61. PubMed ID: 11836383
[TBL] [Abstract][Full Text] [Related]
14. Mixed infection with herpes simplex virus type 1 generates recombinants with increased ocular and neurovirulence.
Brandt CR; Grau DR
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2214-23. PubMed ID: 2173682
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
16. Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.
Lee K; Kolb AW; Larsen I; Craven M; Brandt CR
J Virol; 2016 Sep; 90(18):8115-31. PubMed ID: 27384650
[TBL] [Abstract][Full Text] [Related]
17. A Mutation in the
Dridi S; Richerioux N; Gonzalez Suarez CE; Vanharen M; Sanabria-Solano C; Pearson A
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068651
[TBL] [Abstract][Full Text] [Related]
18. A novel, cell-specific attenuation of a herpes simplex virus type 1 infection in vivo.
Kienzle TE; Chen TM; Mrak RE; Stroop WG
Acta Neuropathol; 2001 Apr; 101(4):341-50. PubMed ID: 11355305
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system.
Carr DJ; Campbell IL
Viral Immunol; 2006; 19(4):741-6. PubMed ID: 17201669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
